Iovance Biotherapeutics: Several Positives, But Competition Still Threatens
Source: SeekingAlpha
2025-11-24 12:56:15 ET
Read the full article on Seeking Alpha
For further details see:
Iovance Biotherapeutics: Several Positives, But Competition Still Threatens
Immatics N.V.
NASDAQ: IMTX
IMTX Trading
-2.95% G/L:
$9.20 Last:
119,290 Volume:
$9.52 Open:
IMTX Latest News
February 05, 2026 08:32:00 am
Big Pharma's $170B Panic: Why Capital Is Rotating to Clinical Stage Oncology
IMTX Stock Data
$1,341,978,928
63,814,383
N/A
32
N/A
Biotechnology & Life Sciences
Healthcare
DE
Tbingen
